Here we demonstrate that in agreement with the results by Krings and Chen12 at variance with other forms of triple-negative breast cancer, TERT promoter hotspot mutations and gene amplification are found in substantial subset of MBCs (17%), and that these alterations are less frequently found in MBCs with a predominant chondroid component. This evidence concerns the gene TERT and triple-negative breast carcinoma.